(Q54440561)

29 May 2018

title

Resistin gene promoter region polymorphism and the risk of hypertrophic cardiomyopathy in patients. (English)

1 reference

29 May 2018

hypertrophic cardiomyopathy

main subject

1 reference

Sabir Hussain

1

1 reference

29 May 2018

Muhammad Asghar

series ordinal

2

1 reference

29 May 2018

Qamar Javed

series ordinal

3

1 reference

29 May 2018

publication date

4 November 2009

1 reference

29 May 2018

published in

Translational Research

1 reference

29 May 2018

volume

155

1 reference

29 May 2018

issue

3

1 reference

29 May 2018

page(s)

142-147

1 reference

29 May 2018

The management of hypertrophic cardiomyopathy

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.10.002

Somatic events modify hypertrophic cardiomyopathy pathology and link hypertrophy to arrhythmia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.10.002

Hypertrophic cardiomyopathy in a large community-based population: clinical outcome and identification of risk factors for sudden cardiac death and clinical deterioration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.10.002

First mutation in cardiac troponin C, L29Q, in a patient with hypertrophic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.10.002

Myosin light chain mutation causes autosomal recessive cardiomyopathy with mid-cavitary hypertrophy and restrictive physiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.10.002

Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.10.002

Tcap gene mutations in hypertrophic cardiomyopathy and dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.10.002

The hormone resistin links obesity to diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.10.002

Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.10.002

Relationship between resistin level in serum and acute coronary syndrome or stable angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.10.002

Novel resistin promoter polymorphisms: association with serum resistin level in Japanese obese individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.10.002

The G/G genotype of a resistin single-nucleotide polymorphism at -420 increases type 2 diabetes mellitus susceptibility by inducing promoter activity through specific binding of Sp1/3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.10.002

A polymorphism in the resistin gene promoter and the risk of coronary artery disease in a Chinese population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.10.002

Resistin polymorphisms are associated with cerebrovascular disease in Finnish Type 2 diabetic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.10.002

Role of resistin in cardiac contractility and hypertrophy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.10.002

Experience from clinical genetics in hypertrophic cardiomyopathy: proposal for new diagnostic criteria in adult members of affected families

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.10.002

Polymorphism in resistin promoter region at -420 determines the serum resistin levels and may be a risk marker of stroke in Japanese type 2 diabetic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.10.002

Plasma resistin associated with myocardium injury in patients with acute coronary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.10.002

Resistin is an inflammatory marker of atherosclerosis in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.10.002

Plasma resistin levels and risk of myocardial infarction and ischemic stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.10.002

Serum resistin is associated with high risk in patients with congestive heart failure--a novel link between metabolic signals and heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.10.002

Resistin SNP-420 determines its monocyte mRNA and serum levels inducing type 2 diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.10.002

10.1016/J.TRSL.2009.10.002

7 January 2021

Identifiers

DOI

1 reference

29 May 2018

1 reference

29 May 2018